UBX: Unity Biotechnology, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Unity Biotechnology, Inc.

NASDAQ:UBX

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$0.07
Loss Chance
59.6%
0.03JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Biogen
NASDAQ:BIIB
5.83
$196.97
14.45%
BioMarin Pharmaceutical
NASDAQ:BMRN
6.13
$52.38
7.74%
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.36
$31.32
42.58%
Halozyme Therapeutics
NASDAQ:HALO
6.26
$68.65
55.97%
Myriad Genetics
NASDAQ:MYGN
3.96
$3.93
n/a
Jitta Factors
Growth Opportunity (19)
Recent Business Performance (25)
Financial Strength (6)
Return to Shareholders (0)
Competitive Advantage (9)
Jitta Signs
Operating MarginInconsistent
Recent Business PerformanceEarning decline 48.31% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.03
100.00%
2.21
139.77%
3.06
206.85%
Biotechnology
5.83
14.45%
6.13
7.74%
6.36
42.58%
COMPANY DESCRIPTION
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. Its lead drug candidate includes UBX1325, which is Phase 2 clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. The company also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2048, a Tie2/VEGF bispecific; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of eye diseases; and UBX2089, an a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.
unitybiotechnology.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.